Abstract
Clinical Perspectives of Mesenchymal Stem Cells
Highlights
Culture of Mesenchymal stem cells (MSCs) has already been established in the early 1960s when fibroblastoid cells were discussed as supportive stromal cells within the hematopoietic bone marrow niche
Mesenchymal stem cells (MSCs) raise high hopes for regenerative medicine—they have already paved their way to a large number of clinical trials for a broad range of diseases
Preliminary results with MSCs are promising for the treatment of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation
Summary
Culture of MSCs has already been established in the early 1960s when fibroblastoid cells were discussed as supportive stromal cells within the hematopoietic bone marrow niche. Editorial Clinical Perspectives of Mesenchymal Stem Cells Jan Kramer,[1] Francesco Dazzi,[2] Massimo Dominici,[3] Peter Schlenke,[4] and Wolfgang Wagner[5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
